P
Paolo Vallone
Researcher at National Institutes of Health
Publications - 46
Citations - 3289
Paolo Vallone is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Radiofrequency ablation & Hepatocellular carcinoma. The author has an hindex of 17, co-authored 43 publications receiving 3129 citations.
Papers
More filters
Journal ArticleDOI
Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients
Steven A. Curley,Francesco Izzo,Paolo Delrio,Lee M. Ellis,Jennifer Granchi,Paolo Vallone,Francesco Fiore,Sandro Pignata,Bruno Daniele,F. Cremona +9 more
TL;DR: RFA is a safe, well-tolerated, and effective treatment to achieve tumor destruction in patients with unresectable hepatic malignancies and multimodality treatment approaches that include RFA should be investigated.
Journal ArticleDOI
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
TL;DR: In patients with cirrhosis and HCC, RFA produces effective local control of disease in a significant proportion of patients and can be performed safely with minimal complications.
Journal ArticleDOI
Early and Late Complications After Radiofrequency Ablation of Malignant Liver Tumors in 608 Patients
Steven A. Curley,Paolo Marra,Karen A. Beaty,Lee M. Ellis,J. Nicolas Vauthey,Eddie K. Abdalla,Courtney L Scaife,Chan Raut,Robert A. Wolff,Haesun Choi,Evelyne M. Loyer,Paolo Vallone,Francesco Fiore,Fabrizio Scordino,Vincenzo De Rosa,Raffaele Orlando,Sandro Pignata,Bruno Daniele,Francesco Izzo +18 more
TL;DR: Hepatic tumor RFA can be performed with low mortality and morbidity rates, though relatively rare, late complications can develop and physicians performing hepatic RFA must be cognizant of these delayed treatment-related problems.
Journal ArticleDOI
Pegylated Arginine Deiminase Treatment of Patients With Unresectable Hepatocellular Carcinoma: Results From Phase I/II Studies
Francesco Izzo,Paolo Marra,Gerardo Beneduce,Giuseppe Castello,Paolo Vallone,Vincenzo De Rosa,Franco Cremona,C. Mark Ensor,Frederick W. Holtsberg,John S. Bomalaski,Mike A. Clark,Chaan S. Ng,Steven A. Curley +12 more
TL;DR: Elimination of all detectable plasma arginine in patients with HCC was well tolerated and seemed to be effective in the treatment of some patients in a cohort dose-escalation phase I/II study.
Journal ArticleDOI
Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis
Chandrajit P. Raut,Francesco Izzo,Paolo Marra,Lee M. Ellis,Jean Nicolas Vauthey,F. Cremona,Paolo Vallone,Angelo A. Mastro,Bruno D. Fornage,Steven A. Curley +9 more
TL;DR: Treatment with RFA can produce significant long-term survival rates for cirrhotic patients with early-stage, unresectable HCC and can be performed in these patients with relatively low complication rates.